Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer-Reference-Cited by-同舟云学术

Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer

Published:2017-08-25 Issue:1 Volume:14 Page:91-100
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Takhar Harminder¹^ORCID,Singhal Nimit¹,Mislang Anna¹,Kumar Raj²,Kim Laurence¹,Selva-Nayagam Sid¹,Pittman Ken³,Karapetis Chris²,Borg Martin⁴,Olver Ian N.⁵,Brown Michael P.¹⁵⁶⁷

Affiliation:

1. Cancer Clinical Trials Unit; Royal Adelaide Hospital; Adelaide South Australia Australia

2. Department of Medical Oncology; Flinders Medical Centre and Flinders University; Adelaide South Australia Australia

3. Department of Medical Oncology; The Queen Elizabeth Hospital; Woodville South Australia Australia

4. Adelaide Radiotherapy Centre; Adelaide South Australia Australia

5. Sansom Institute; University of South Australia; Adelaide South Australia Australia

6. Centre for Cancer Biology; SA Pathology and University of South Australia; Adelaide South Australia Australia

7. Discipline of Medicine; University of Adelaide; Adelaide South Australia Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12749/fullpdf

Reference39 articles.

1. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105;Yamamoto;J Clin Oncol,2010

2. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: The Hoosier Oncology Group and U.S. Oncology;Hanna;J Clin Oncol.,2008

3. Definitive chemoradiation for the treatment of locally advanced non-small cell lung cancer;Blackstock;J Clin Oncol,2007

4. Concurrent cisplatin, etoposide and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer (SWOG 9019);Albain;J Clin Oncol.,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilayer nanodrug delivery system with spatiotemporal drug release improves tumor microenvironment for synergistic anticancer therapy;Biofabrication;2024-02-07

2. The role of lipid metabolism in cancer radioresistance;Clinical and Translational Oncology;2023-04-20

3. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31

4. Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies;Nanomedicine;2021-08

5. Recent Advances and Challenges in Controlling the Spatiotemporal Release of Combinatorial Anticancer Drugs from Nanoparticles;Pharmaceutics;2020-11-27